BRIEF-AstraZeneca Says Lynparza Combo Recommended In EU For mCRPC


Reuters | Updated: 14-11-2022 12:54 IST | Created: 14-11-2022 12:50 IST
BRIEF-AstraZeneca Says Lynparza Combo Recommended In EU For mCRPC
AstraZeneca logo Image Credit: ANI

AstraZeneca PLC: * ASTRAZENECA PLC - LYNPARZA COMBO RECOMMENDED IN THE EU FOR MCRPC

* ASTRAZENECA PLC - LYNPARZA COMBO RECOMMENDED IN THE EU FOR MCRPC * ASTRAZENECA - LYNPARZA IN COMBINATION WITH ABIRATERONE RECOMMENDED FOR APPROVAL IN EU BY CHMP Source text for Eikon: Further company coverage:

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)

Give Feedback